175 related articles for article (PubMed ID: 32747505)
21. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance.
Shimoda M; Mmanywa F; Joshi SK; Li T; Miyake K; Pihkala J; Abbas JA; Koni PA
J Immunol; 2006 Jun; 176(11):6503-11. PubMed ID: 16709807
[TBL] [Abstract][Full Text] [Related]
22. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
23. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
24. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells.
Brocker T
J Exp Med; 1997 Oct; 186(8):1223-32. PubMed ID: 9334361
[TBL] [Abstract][Full Text] [Related]
25. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells.
Furuta K; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19380-5. PubMed ID: 23129633
[TBL] [Abstract][Full Text] [Related]
26. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
Cho KJ; Ishido S; Eisenlohr LC; Roche PA
J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
[TBL] [Abstract][Full Text] [Related]
27. Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes.
Gommeaux J; Grégoire C; Nguessan P; Richelme M; Malissen M; Guerder S; Malissen B; Carrier A
Eur J Immunol; 2009 Apr; 39(4):956-64. PubMed ID: 19283781
[TBL] [Abstract][Full Text] [Related]
28. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways.
Buschow SI; Nolte-'t Hoen EN; van Niel G; Pols MS; ten Broeke T; Lauwen M; Ossendorp F; Melief CJ; Raposo G; Wubbolts R; Wauben MH; Stoorvogel W
Traffic; 2009 Oct; 10(10):1528-42. PubMed ID: 19682328
[TBL] [Abstract][Full Text] [Related]
29. Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC.
Martinic MM; van den Broek MF; Rülicke T; Huber C; Odermatt B; Reith W; Horvath E; Zellweger R; Fink K; Recher M; Eschli B; Hengartner H; Zinkernagel RM
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14435-40. PubMed ID: 16983067
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86.
Liu H; Wilson KR; Firth AM; Macri C; Schriek P; Blum AB; Villar J; Wormald S; Shambrook M; Xu B; Lim HJ; McWilliam HEG; Hill AF; Edgington-Mitchell LE; Caminschi I; Lahoud MH; Segura E; Herold MJ; Villadangos JA; Mintern JD
Nat Commun; 2022 Apr; 13(1):1934. PubMed ID: 35411049
[TBL] [Abstract][Full Text] [Related]
31. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
32. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
33. The Salmonella Effector SteD Mediates MARCH8-Dependent Ubiquitination of MHC II Molecules and Inhibits T Cell Activation.
Bayer-Santos E; Durkin CH; Rigano LA; Kupz A; Alix E; Cerny O; Jennings E; Liu M; Ryan AS; Lapaque N; Kaufmann SHE; Holden DW
Cell Host Microbe; 2016 Nov; 20(5):584-595. PubMed ID: 27832589
[TBL] [Abstract][Full Text] [Related]
34. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
Periasamy P; O'Neill HC
Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
[TBL] [Abstract][Full Text] [Related]
35. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell-MHC class II and Itk regulate functional development of regulatory innate memory CD4+ T cells in bone marrow transplantation.
Huang W; Qi Q; Hu J; Huang F; Laufer TM; August A
J Immunol; 2014 Apr; 192(7):3435-3441. PubMed ID: 24610010
[TBL] [Abstract][Full Text] [Related]
37. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
Nasreen M; Ueno T; Saito F; Takahama Y
J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
[TBL] [Abstract][Full Text] [Related]
38. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
39. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
[TBL] [Abstract][Full Text] [Related]
40. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF
J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
